The Competition and Markets Authority has decided against investigating medicine stock shortages in the UK. It says it has other priorities and there is not enough persuasive evidence to justify an investigation. It claimed it was not the best-placed organisation to carry out an investigation even if one was needed. The CMA had found little […]
Novartis, the big pharma company, has agreed to pay US$390m in a settlement with the US Department of Justice over what the DoJ alleged were kickbacks paid to US specialty pharmacies for encouraging patients to refill their prescriptions with Novartis’s Medicaid and Medicare products. Payments had been made by Novartis between 2007 and 2012.
Work has started on the construction of the world’s first cell and gene therapy centre at Stevenage Bioscience Catalyst, the UK’s pioneering life sciences open innovation campus. The £55m project for Cell Therapy Catapult is expected to be completed in 2017 with 150 new jobs working on the manufacture of different cell therapies for late […]
Warner-Lambert v Sandoz and Lloyds Pharmacy, High Court
The High Court has granted interim injunctions preventing Sandoz from trading in full label generic pregabalin and Lloyds Pharmacy from dispensing such product.
The case concerns the pharmaceutical product, pregabalin, marketed by Pfizer under the brand name, Lyrica. Warner-Lambert, which is part of the Pfizer group, […]